Grants per year
Fingerprint
Dive into the research topics where Johanna Melo-Cardenas is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Grants
- 1 Finished
-
Research supplement for aberrant megakaryopoiesis in the myeloproliferative neoplasms
Crispino, J. D. (PD/PI) & Melo-Cardenas, J. (Subproject PI)
National Heart, Lung, and Blood Institute
5/1/17 → 8/31/20
Project: Research project
-
CALR goes rogue
Melo-Cardenas, J. & Crispino, J. D., Feb 23 2023, In: Blood. 141, 8, p. 818-820 3 p.Research output: Contribution to journal › Editorial › peer-review
Open Access -
IL-13/IL-4 signaling contributes to fibrotic progression of the myeloproliferative neoplasms
Melo-Cardenas, J., Bezavada, L., Crawford, J. C., Gurbuxani, S., Cotton, A., Kang, G., Gossett, J., Marinaccio, C., Weinberg, R., Hoffman, R., Migliaccio, A. R., Zheng, Y., Derecka, M., Rinaldi, C. R. & Crispino, J. D., Dec 29 2022, In: Blood. 140, 26, p. 2805-2817 13 p.Research output: Contribution to journal › Article › peer-review
Open Access20 Scopus citations -
Resident Self-Tissue of Proinflammatory Cytokines Rather than Their Systemic Levels Correlates with Development of Myelofibrosis in Gata1low Mice
Zingariello, M., Verachi, P., Gobbo, F., Martelli, F., Falchi, M., Mazzarini, M., Valeri, M., Sarli, G., Marinaccio, C., Melo-Cardenas, J., Crispino, J. D. & Migliaccio, A. R., Feb 2022, In: Biomolecules. 12, 2, 234.Research output: Contribution to journal › Article › peer-review
Open Access6 Scopus citations -
The Role of Megakaryocytes in Myelofibrosis
Melo-Cardenas, J., Migliaccio, A. R. & Crispino, J. D., Apr 2021, In: Hematology/Oncology Clinics of North America. 35, 2, p. 191-203 13 p.Research output: Contribution to journal › Review article › peer-review
Open Access12 Scopus citations -
The E3 ligase Hrd1 stabilizes Tregs by antagonizing inflammatory cytokine-induced ER stress response
Xu, Y., Melo-Cardenas, J., Zhang, Y., Gau, I., Wei, J., Montauti, E., Zhang, Y., Gao, B., Jin, H., Sun, Z., Lee, S. M. & Fang, D., Mar 7 2019, In: JCI Insight. 4, 5Research output: Contribution to journal › Article › peer-review
Open Access42 Scopus citations